Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy E Rose

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Dermatology Online Journal|December 25, 2013
Livedo reticularisAmy E Rose, Vishal Sagger, Kevin P Boyd, et al.
The Journal of Urology|February 23, 2010
Outcomes of patients lost to followup after mid urethral synthetic slings--successes or failures?Katie N Ballert, Amy E Rose, Grace Y Biggs, et al.
Dermatology Online Journal|December 25, 2013
SyringocystadenomaJyoti P Mundi, Amy E Rose, Kevin P Boyd, et al.
Dermatology Online Journal|October 28, 2011
Erythrodermic lichen planusAmy E Rose, Utpal Patel, Julie Chu, et al.
The American Journal of Surgical Pathology|September 2, 2011
Clinical relevance of detection of lymphovascular invasion in primary melanoma using endothelial markers D2-40 and CD34Amy E Rose, Paul J Christos, Dan Lackaye, et al.
Cancer|October 25, 2011
Impact of race on survival in patients with clinically nonmetastatic prostate cancer who deferred primary treatmentMichael Koscuiszka, David Hatcher, Paul J Christos, et al.
Cancer|April 8, 2011
Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survivalJan Zakrzewski, Laurel N Geraghty, Amy E Rose, et al.
Journal of Translational Medicine|February 25, 2010
Increased shedding of HU177 correlates with worse prognosis in primary melanomaHeather K Hamilton, Amy E Rose, Paul J Christos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Melanoma MicroRNA signature predicts post-recurrence survivalMiguel F Segura, Ilana Belitskaya-Lévy, Amy E Rose, et al.
Pigment Cell & Melanoma Research|October 2, 2010
Clinical relevance of SKP2 alterations in metastatic melanomaAmy E Rose, Guimin Wang, Douglas Hanniford, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Dermatology Online Journal|December 25, 2013
Livedo reticularisAmy E Rose, Vishal Sagger, Kevin P Boyd, et al.
The Journal of Urology|February 23, 2010
Outcomes of patients lost to followup after mid urethral synthetic slings--successes or failures?Katie N Ballert, Amy E Rose, Grace Y Biggs, et al.
Dermatology Online Journal|December 25, 2013
SyringocystadenomaJyoti P Mundi, Amy E Rose, Kevin P Boyd, et al.
Dermatology Online Journal|October 28, 2011
Erythrodermic lichen planusAmy E Rose, Utpal Patel, Julie Chu, et al.
The American Journal of Surgical Pathology|September 2, 2011
Clinical relevance of detection of lymphovascular invasion in primary melanoma using endothelial markers D2-40 and CD34Amy E Rose, Paul J Christos, Dan Lackaye, et al.
Cancer|October 25, 2011
Impact of race on survival in patients with clinically nonmetastatic prostate cancer who deferred primary treatmentMichael Koscuiszka, David Hatcher, Paul J Christos, et al.
Cancer|April 8, 2011
Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survivalJan Zakrzewski, Laurel N Geraghty, Amy E Rose, et al.
Journal of Translational Medicine|February 25, 2010
Increased shedding of HU177 correlates with worse prognosis in primary melanomaHeather K Hamilton, Amy E Rose, Paul J Christos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Melanoma MicroRNA signature predicts post-recurrence survivalMiguel F Segura, Ilana Belitskaya-Lévy, Amy E Rose, et al.
Pigment Cell & Melanoma Research|October 2, 2010
Clinical relevance of SKP2 alterations in metastatic melanomaAmy E Rose, Guimin Wang, Douglas Hanniford, et al.
Pageof 3